- Baxter International (NYSE:BAX) Q4 results: Revenues: $2,603M (-6.7%); R&D Expense: $161M (+3.2%); SG&A: $733M (-14.8%); Operating Income: $178M (-6.8%); Net Income: $190M (+49.6%); EPS: $0.34 (+47.8%); Non-GAAP EPS: $0.43 (+53.6%).
-
FY2015 results: Revenues: $9,968M (-7.0%); R&D Expense: $603M (-1.1%); SG&A: $3,094M (-6.7%); Operating Income: $449M (-31.6%); Net Income: $400M (-12.5%); EPS: $0.73 (-12.0%); Non-GAAP EPS: $1.38 (+7.8%).
-
Q1 Guidance: EPS before special items: $0.28 - 0.30.
-
2016 Guidance: EPS before special items: $1.46 - 1.54.